Wolfe Research has increased its price target for Johnson Controls (JCI) to $171 from $165, reiterating an Outperform rating due to the company's "lean transformation" showing tangible progress. UBS also raised its price target to $180 from $170, maintaining a Buy rating, noting promising early signs of an operational turnaround. Johnson Controls, a global technology company focused on energy efficiency and decarbonization, is seen by analysts as successfully implementing its strategic initiatives.

Merck & Co., Inc. (MRK) is reportedly in discussions with global health authorities to make its COVID-19 antiviral pill, molnupiravir, a potential treatment for the rare Bundibugyo strain of the Ebola virus. This initiative comes in response to a growing outbreak in the Democratic Republic of Congo, where there are currently no approved vaccines or treatments for this specific Ebola variant. While molnupiravir is not officially approved for Ebola, animal studies suggest it could be effective in preventing infections among high-risk individuals.

Hycroft Mining Holding Corp's SVP & General Counsel, Rebecca Jennings, sold 11,300 shares of Class A common stock at a weighted average price of $30.27 per share. This transaction was conducted to cover tax obligations related to vested restricted stock units. After the sale, Jennings still directly holds 204,494 shares, including 199,104 unvested RSUs, demonstrating a continued substantial equity stake in the company.

Apollo Global Management and Blackstone Group have finalized a $35 billion private credit deal for AI firm Anthropic, aimed at funding its computing power expansion through "chip financing." This innovative financing uses a Special Purpose Vehicle (SPV) to purchase Google's custom Tensor Processing Units, which are then leased to Anthropic, with Broadcom providing crucial credit endorsements and residual value guarantees for significant debt tranches. This deal, one of the largest private credit transactions to date, facilitates Anthropic's rapid growth and infrastructure needs amidst an active IPO landscape, highlighting new debt structuring in the tech sector.

Goldman Sachs recently lowered its price target for Amgen (AMGN) from $425 to $389 but maintained a Buy rating, following an escalated IRS audit dispute revealed in Amgen's first-quarter earnings. Piper Sandler also reduced its price target for Amgen to $427 from $432, while still seeing revenue growth potential driven by its rare disease business and Tepezza. Amgen is identified as a profitable dividend stock, but the article suggests other AI stocks might offer greater upside with less risk.

Daniel S. Fishbein, Executive Vice President, General Counsel, and Secretary of Graphic Packaging Holding Co (NYSE: GPK), has filed an initial Form 3 insider report. This filing establishes his status as a reporting insider but does not indicate any beneficial ownership of securities or report any transactions. The report clarifies that he is not a director or a ten percent owner, focusing solely on documenting his position as an officer of the company.

GXO Logistics Inc. has appointed Roberto Pascual as the new Managing Director for Spain and Portugal. Pascual, with over 25 years of experience in contract logistics from DHL Supply Chain, will focus on enhancing customer-centricity and expanding automation. This appointment follows the successful tenure of Rui Marques, who has moved to lead one of GXO's key global customer accounts.

Five9 CFO Lee Bryan M sold 18,131 shares of company stock for approximately $449,059 on June 4 and 5, 2026. These sales, conducted under a Rule 10b5-1 trading plan and for tax withholding purposes, occurred at weighted average prices between $24.16 and $25.69 per share. Following these transactions, Mr. Lee directly holds 309,951 shares, while the company has recently reported strong first-quarter earnings and raised annual revenue guidance.

Ibotta, Inc. CTO Luke Roy Swanson sold 11,880 shares of Class A Common Stock on June 4, 2026, through a pre-arranged Rule 10b5-1 trading plan. The sales occurred at weighted average prices between $32.86 and $33.71 per share. Despite these sales, Swanson retains significant direct and indirect holdings, including restricted stock units, demonstrating his continued economic interest in the company.

This article from Stock Traders Daily provides an AI-generated analysis of Ishares Ibonds Dec 2033 Term Corporate Etf (NASDAQ: IBDY). It highlights a neutral sentiment across all time horizons, suggesting a wait-and-see approach, and identifies elevated downside risk. The report also details institutional trading strategies, including position trading, momentum breakout, and risk hedging, with specific entry zones, targets, and stop losses.